Cobalt Ferrite Nanoparticles for Hyperthermia Efficiency

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current magnetic nanoparticles, particularly iron oxides, exhibit low hyperthermic efficiency and stability issues in physiological environments, requiring high concentrations for therapeutic effects, and existing methods for producing nanoparticles with controlled size and stability are complex and costly.

Innovation Solution

Development of magnetic nanometric particles, such as spinels like cobalt ferrite, magnetite, and maghemite, functionalized with bifunctional compounds and incorporated into polymers with external protecting layers, using controlled synthesis methods to achieve high hyperthermic efficiency and stability at low concentrations.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Power

If iron oxide nanoparticles are used for hyperthermia treatment, then the therapeutic effect is achieved, but high concentrations are required due to low hyperthermic efficiency

Engineering Contradiction:
Improvehyperthermic efficiencyVSAvoidconcentration of nanoparticles
Core Design Contradiction:
PowerVSQuantity of substance

Solution Approach 1:

The patent changes the material parameter from iron oxide to cobalt ferrite, which fundamentally alters the hyperthermic efficiency. Cobalt ferrite exhibits approximately one order of magnitude higher hyperthermic efficiency compared to iron oxides, allowing therapeutic effects to be achieved at much lower concentrations. This material substitution resolves the contradiction by improving the power output (hyperthermic efficiency) while reducing the quantity of substance required.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent employs composite structures by functionalizing cobalt ferrite nanoparticles with bifunctional compounds and incorporating them into polymer matrices with external protecting layers. This composite approach enhances the intrinsic hyperthermic efficiency of the core material while providing stability and biocompatibility, thereby achieving high therapeutic efficacy at low concentrations without compromising particle stability.

Inventive Principle:
Principle #40Composite materials

2Adaptability or versatility

If magnetic nanoparticles are used in physiological environments, then therapeutic applications are enabled, but stability issues occur

Engineering Contradiction:
Improvetherapeutic application capabilityVSAvoidstability in physiological environment
Core Design Contradiction:
Adaptability or versatilityVSStability of the object's composition

Solution Approach 1:

The patent implements a nested structure where cobalt ferrite nanoparticles are functionalized with bifunctional compounds that serve as inner layers, which are then incorporated into polymer matrices that act as intermediate layers, and finally coated with external protecting layers. This multi-layer nested architecture provides progressive protection, maintaining particle stability in physiological environments while preserving therapeutic functionality.

Inventive Principle:
Principle #7Nested doll (Nesting)

Solution Approach 2:

The patent creates composite materials by combining cobalt ferrite with polymers and surface agents. The polymer matrix provides structural stability and controlled release properties, while the external protecting layers (surface agents) enhance colloidal stability and biocompatibility in physiological environments. This composite approach resolves the contradiction between enabling therapeutic applications and maintaining stability.

Inventive Principle:
Principle #40Composite materials

3Ease of manufacture

If existing methods are used to produce magnetic nanoparticles, then particles can be obtained, but the processes are complex and costly

Engineering Contradiction:
Improveproduction complexity and costVSAvoidsize control and stability
Core Design Contradiction:
Ease of manufactureVSManufacturing precision

Solution Approach 1:

The patent employs preliminary functionalization of cobalt ferrite nanoparticles with bifunctional compounds during the synthesis process itself, rather than requiring separate post-synthesis modification steps. The bifunctional compounds are introduced in the initial synthesis stage, enabling direct incorporation into the polymer matrix without additional complex processing. This preliminary action simplifies the overall manufacturing process while maintaining precise size control and stability.

Inventive Principle:
Principle #10Preliminary action

4Power

If high concentrations of magnetic nanoparticles are used, then therapeutic effects are achieved, but the complexity of formulation increases

Engineering Contradiction:
Improvehyperthermic effectVSAvoidformulation complexity
Core Design Contradiction:
PowerVSDevice complexity

Solution Approach 1:

The patent fundamentally changes the material parameter from iron oxide to cobalt ferrite, which increases hyperthermic efficiency by approximately one order of magnitude. This parameter change allows achieving the same therapeutic effect at much lower concentrations, thereby simplifying the formulation process and reducing formulation complexity while maintaining the required hyperthermic power output.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The resulting nanoparticles demonstrate enhanced hyperthermic efficiency and stability, allowing for effective therapeutic applications at lower concentrations and improved biocompatibility, with cobalt ferrite showing approximately one order of magnitude higher efficiency than iron oxides and maintaining efficiency in fluid matrices.

Implementation Method 1

The actual usefulness of the magnetic nanoparticles is, in the ultimate analysis, related to their ability to increase the temperature of the medium in which they are confined when interacting with an external electromagnetic fields.

Methodology Applied
Scientific EffectHyperthermic effect: Electromagnetic Induction

Implementation Method 2

magnetic nanoparticles have their potential field of application in the diagnostic sector as a contrast medium in imaging techniques (magnetic resonance), in the magnetic localisation techniques and, mainly, in the specifically therapeutic field of hyperthermia mediated by magnetic fields.

Methodology Applied
Scientific EffectMagnetic field interaction: Magnetic Field

Implementation Method 3

cobalt ferrite showing approximately one order of magnitude higher efficiency than iron oxides and maintaining efficiency in fluid matrices.

Methodology Applied
Scientific EffectMagnetic hyperthermia: Magnetic Hysteresis

Data Source

PatentUS8501159B2Magnetic nanoparticles for the application in hyperthermia, preparation thereof and use in constructs having a pharmacological application
Publication Date: 2013.08.06 COLOROBBIA ITALA
  • US8501159B2 patent drawing
  • US8501159B2 patent drawing
  • US8501159B2 patent drawing

AI summary

There are described nanoparticles of magnetic metal oxides employable in constructs consisting in polymer particles possibly also incorporating pharmacologically active substances.